Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders

J Wolff, P Reißner, G Hefner, C Normann, K Kaier… - PLoS …, 2021 - journals.plos.org
Introduction The aim of this study was to describe the number and type of drugs used to treat
depressive disorders in inpatient psychiatry and to analyse the determinants of potential …

Time trends in pharmacological treatment of major depressive disorder: results from the AMSP Pharmacovigilance Program from 2001–2017

J Seifert, RR Engel, X Bernegger, F Führmann… - Journal of Affective …, 2021 - Elsevier
Background: Currently available data on the prescription practice among patients with major
depressive disorder (MDD) reflect the outpatient setting. This is the first study to provide …

Rates and determinants of use of pharmacotherapy and psychotherapy by patients with major depressive disorder

FW Gaspar, CS Zaidel, CS Dewa - Psychiatric Services, 2019 - Am Psychiatric Assoc
Objective: Rates and determinants of pharmacological and psychotherapy use were
assessed after a major depressive disorder diagnosis. Methods: In a retrospective claims …

Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001 …

J Seifert, HB Maier, F Führmann, S Bleich… - Journal of Neural …, 2022 - Springer
Abstract The International Classification of Diseases (10th Version) categorizes major
depressive disorder (MDD) according to severity. Guidelines provide recommendations for …

Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study

HD Anderson, WD Pace, AM Libby, DR West… - Clinical …, 2012 - Elsevier
BACKGROUND: Antidepressants are the first-line treatment for depression, yet medication-
related side effects may be associated with antidepressant discontinuation before reaching …

[HTML][HTML] Potential drug-drug interactions in outpatients with depression of a psychiatry department

Y Chen, L Ding - Saudi Pharmaceutical Journal, 2023 - Elsevier
Objective This study aims to explore the prevalence and associated risk factors for potential
drug-drug interactions (pDDIs) in prescriptions among outpatients with depression, and …

[HTML][HTML] Antidepressant efficacy and side effect burden: an updated guide for clinicians

T Kutzer, M Dick, T Scudamore, M Wiener… - Drugs in …, 2020 - ncbi.nlm.nih.gov
Antidepressant treatment has been evolving and changing since the 1950s following the
discovery of the classic antidepressant treatments including tricyclic antidepressants and …

Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program

A Konstantinidis, K Papageorgiou… - International Journal …, 2012 - academic.oup.com
While international guidelines recommend monotherapy with antidepressants for depressed
patients, recent investigation has demonstrated augmenting effects of antipsychotics (APs) …

Efficacy and safety of antidepressants in patients with comorbid depression and medical diseases: an umbrella systematic review and meta-analysis

O Köhler-Forsberg, V Stiglbauer, J Brasanac… - JAMA …, 2023 - jamanetwork.com
Importance Every third to sixth patient with medical diseases receives antidepressants, but
regulatory trials typically exclude comorbid medical diseases. Meta-analyses of …

Depression treatment in patients with general medical conditions: results from the CO-MED trial

DW Morris, N Budhwar, M Husain… - The Annals of Family …, 2012 - Annals Family Med
PURPOSE We studied the effect of 3 antidepressant treatments on outcomes (depressive
severity, medication tolerability, and psychosocial functioning) in depressed patients having …